2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Critically Ill: new trials by email Literature Review of Critically Ill trials Research Report on Critically Ill
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Collaborative H1N1 Adjuvant Treatment Pilot Trial Rosuvastatin, Placebo - Critically Ill, H1N1/Influenza Infection | Phase 2 | Terminated | Canadian Critical Care Trials Group | 8 | 2010-01-01 | 2013-02-21 |
| The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients Glucagon-Like Peptide-1, Saline - Critically Ill, Hypoglycemia | Phase 2 | Terminated | Johns Hopkins University | 19 | 2008-12-01 | 2017-07-02 |
Critical Illness (2) · Hypoglycemia (1) · Respiratory Aspiration (1)
Disease Attributes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Respiration Disorders (1) · Respiratory Tract Diseases (1)
Glucagon-Like Peptide 1 (1) · Rosuvastatin Calcium (1) · Sodium Chloride (1)
Canadian Critical Care Trials Group (1) · Johns Hopkins University (1)
Canada (1) · United States (1)
Dariush Elahi, PhD (1) · John C Marshall, MD, FRCPS (1) · Karen EA Burns, MD,FRCPC,MSc (1)